Cannabidiol (CBD), the major non-psychoactive phytocannabinoid of Cannabis sativa L., is
one of the most studied compounds in pharmacotherapeutic approaches to treat oxidative …

Cannabinoids have been utilized for recreational and therapeutic purposes for over 4,000
years. As the primary ingredient in exogenous cannabinoids, Cannabidiol (CBD) has drawn …

Emerging evidence suggests that chemotherapeutic agents and targeted anticancer drugs
have serious side effects on the healthy cells/tissues of the patient. To overcome this, the …

Cordyceps sinensis (CS) has been widely used as a dietary supplement or traditional
medicine for the prevention, treatment, and prognostication of various diseases, because of …

There are differing views on cannabis and phytocannabinoid usage in diverse domains of
application. This review explores the advantages and drawbacks of using cannabis and …

Emerging insights into iron-dependent form of regulated cell death ferroptosis in cancer
have opened a perspective for its use in cancer therapy. Of interest, a systematic profiling of …

Hepatocellular carcinoma (HCC) is responsible for roughly 90% of all cases of primary liver
cancer, and the cases are on the rise. The treatment of advanced HCC is a serious …

Recent research has emphasized the potential of natural and synthetic cannabinoids as
anticancer agents. Yet it remains unclear whether and in which sense cannabinoids affect …

Cancer is the leading cause of morbidity and mortality worldwide and is an important barrier
to lengthening life expectancy in every country. Natural products are receiving increased …

Lung cancer is the first cause of cancer-related deaths in both men and women with an
overall five-year survival rate of 28%. Although immune checkpoint blockers (ICBs) are …